Kiniksa Pharmaceuticals International Plc. Current Cash

Kiniksa Pharmaceuticals International Plc. (KNSA) currently reports a current cash of $180M as of June 2026. That compares with $190M in the prior-year period — down 8.5% year over year. Use the charts on this page to explore Kiniksa Pharmaceuticals International Plc.'s current cash history and peer comparisons.

Kiniksa Pharmaceuticals International Plc.'s current cash decreased from $190M to $180M — a 8.5% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Kiniksa Pharmaceuticals International Plc. reported $180M in current cash as of June 2026. That compares with $190M in the prior-year period — down 8.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $180M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Kiniksa Pharmaceuticals International Plc., and consider following KNSA for alerts when major investors trade the stock.

Kiniksa Pharmaceuticals International Plc. is classified in the Healthcare sector. On current cash, it currently shows $180M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing KNSA with unrelated industries.